Potential role of FLT3-ligand in the angiogenic process of multiple myeloma von Kokonozaki, M, Tsirakis, G, Devetzoglou, M, Kyriakaki, S, Antonakis, A, Vyzoukaki, R, Pappa, C.A, Tzardi, M, Alexandrakis, M.G

Volltext

B cell-activating factor: its clinical significance in multiple myeloma patients von Fragioudaki, M., Boula, A., Tsirakis, G., Psarakis, F., Spanoudakis, M., Papadakis, I. S., Pappa, C. A., Alexandrakis, M. G.

Volltext

P22: A NON‐INTERVENTIONAL, PROSPECTIVE, OBSERVATIONAL STUDY OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IXAZOMIB IN REAL‐WORLD SETTINGS IN GREECE; INTERIM RESULTS... von Katodritou, E, Kyrtsonis, MC, Delimpasi, S, Spanoudakis, E, Vassilopoulos, G, Zikos, P, Viniou, N, Kaiafa, G, Papathanasiou, M, Pappa, V, Michalis, E, Adamopoulos, I, Kokoviadou, K, Tsirakis, G, Poziopoulos, C, Terpos, E

Volltext

Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma von Fragioudaki, M, Tsirakis, G, Pappa, C.A, Aristeidou, I, Tsioutis, C, Alegakis, A, Kyriakou, D.S, Stathopoulos, E.N, Alexandrakis, M.G

Volltext

Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment von Sfiridaki, K., Pappa, C. A., Tsirakis, George, Kanellou, Peggy, Kaparou, Maria, Stratinaki, M., Sakellaris, G., Kontakis, G., Alexandrakis, Michael G.

Volltext

P1646: PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN PATIENTS OLDER THAN 75 YEARS: REAL WORLD DATA FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY von Pontikoglou, C., Matheakakis, A., Stavroulaki, E., Chatzilygeroudi, T., Kourakli, A., Symeonidis, A., Dimou, M., Panayiotidis, P., Drakos, G., Koudouna, A., Galanopoulos, A., Kaliafentaki, V., Kanellou, P., Liapi, D., Tsirakis, G., Kolovou, A., Gavriilaki, E., Syrigou, A., Sakellari, I., Chatzileontiadou, S., Papaioannou, M., Bobola, M., Diamantopoulos, P., Mantzourani, M., Viniou, N.‐A., Dellatola, M., Souravla, A., Pagoni, M., Megalakaki, A., Christodoulou, I., Vlachaki, E., Giannouli, S., Gkalea, V., Matsouka, C., Kotsianidis, I., Vassilopoulos, G., Protopappa, M., Hatzimichael, E., Zikos, P., Chalkiadakis, G. N., Papadaki, H. A.

Volltext

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity von Alexandrakis, M. G., Pappa, C. A., Kokonozaki, M., Boula, A., Vyzoukaki, R., Staphylaki, D., Papadopoulou, A., Androulakis, N., Tsirakis, G., Sfiridaki, A.

Volltext

Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma von Pappa, C.A., Tsirakis, G., Kanellou, P., Kaparou, M., Stratinaki, M., Xekalou, A., Alegakis, A., Boula, A., Stathopoulos, E.N., Alexandrakis, M.G.

Volltext

Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-α in multiple myeloma von Pappa, C. A., Tsirakis, G., Devetzoglou, M., Zafeiri, M., Vyzoukaki, R., Androvitsanea, A., Xekalou, A., Sfiridaki, K., Alexandrakis, M. G.

Volltext

Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients von Pappa, CA, Alexandrakis, MG, Boula, A, Psarakis, FE, Kolovou, A, Bantouna, V, Stavroulaki, E, Tsirakis, G

Volltext

Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma von Tsirakis, G., Pappa, C. A., Psarakis, F. E., Fragioudaki, M., Tsioutis, C., Stavroulaki, E., Boula, A., Alexandrakis, M. G.

Volltext

Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma von Tsirakis, G, Pappa, C.A, Spanoudakis, M, Chochlakis, D, Alegakis, A, Psarakis, F.E, Stratinaki, M, Stathopoulos, E.N, Alexandrakis, M.G

Volltext

Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients von Tsirakis, G, Pappa, C A, Kaparou, M, Katsomitrou, V, Hatzivasili, A, Alegakis, T, Xekalou, A, Stathopoulos, E N, Alexandrakis, M G

Volltext

Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma von Pappa, C. A., Tsirakis, G., Psarakis, F. E., Kolovou, A., Tsigaridaki, M., Stafylaki, D., Sfiridaki, K., Alexandrakis, M. G.

Volltext

Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma von Pappa, C., Miyakis, S., Tsirakis, G., Sfiridaki, A., Alegakis, A., Kafousi, M., Stathopoulos, E.N., Alexandrakis, M.G.

Volltext

P103 Iron chelation treatment in patients with myelodysplastic syndromes (MDS): the experience of the Hellenic MDS Study Group von Kouraklis, A, Symeonidis, A, Galanopoulos, A, Kaiafa, G, Tavernarakis, I, Tsirakis, G, Michali, E, Tsaftaridis, P, Loukidis, K, Aggelidis, A, Zoumbos, N

Volltext

Serum Evaluation of Angiogenic Cytokines Basic Fibroblast Growth Factor, Hepatocyte Growth Factor and TNF-ALPHA in Patients with Myelodysplastic Syndromes: Correlation with Bone Ma... von Alexandrakis, M.G., Passam, F.H., Pappa, C.A., Damilakis, J., Tsirakis, G., Kandidaki, E., Passam, A.M., Stathopoulos, E.N., Kyriakou, D.S.

Volltext

Serum levels of leptin in multiple myeloma patients and its relation to angiogenic and inflammatory cytokines von ALEXANDRAKIS, M. G, PASSAM, F. H, SFIRIDAKI, A, PAPPA, C. A, MOSCHANDREA, J. A, KANDIDAKI, E, TSIRAKIS, G, KYRIAKOU, D. S

Volltext

Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance von PASSAM, F. H., TSIRAKIS, G., BOULA, A., FRAGOU, A., CONSOLAS, I., ALEGAKIS, A., KYRIAKOU, D. S., ALEXANDRAKIS, M. G.

Volltext

Bone marrow mast cell density correlates with serum levels of VEGF and CXC chemokines ENA-78 and GRO-[alpha] in multiple myeloma von Pappa, C A, Tsirakis, G, Devetzoglou, M, Zafeiri, M, Vyzoukaki, R, Androvitsanea, A, Xekalou, A, Sfiridaki, K, Alexandrakis, M G

Volltext